| Product Code: ETC4756152 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
By 2027, the Ophthalmic Drugs market in Mongolia is anticipated to reach a growth rate of 19.78%, as part of an increasingly competitive Asia region, where China remains at the forefront, supported by India, Japan, Australia and South Korea, driving innovations and market adoption across sectors.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mongolia Ophthalmic Drugs Market Overview |
3.1 Mongolia Country Macro Economic Indicators |
3.2 Mongolia Ophthalmic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Mongolia Ophthalmic Drugs Market - Industry Life Cycle |
3.4 Mongolia Ophthalmic Drugs Market - Porter's Five Forces |
3.5 Mongolia Ophthalmic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Mongolia Ophthalmic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Mongolia Ophthalmic Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 Mongolia Ophthalmic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Mongolia Ophthalmic Drugs Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
4 Mongolia Ophthalmic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of eye diseases and disorders in Mongolia |
4.2.2 Rising awareness about eye health and the importance of early treatment |
4.2.3 Growing geriatric population in Mongolia requiring ophthalmic drugs |
4.3 Market Restraints |
4.3.1 Limited access to specialized eye care services in remote areas of Mongolia |
4.3.2 High cost of ophthalmic drugs impacting affordability for some segments of the population |
5 Mongolia Ophthalmic Drugs Market Trends |
6 Mongolia Ophthalmic Drugs Market Segmentations |
6.1 Mongolia Ophthalmic Drugs Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Dry Eye, 2021-2031F |
6.1.3 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Glaucoma, 2021-2031F |
6.1.4 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Infection/Inflammation/Allergy, 2021-2031F |
6.1.5 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Retinal Disorders, 2021-2031F |
6.1.6 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.2 Mongolia Ophthalmic Drugs Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Prescription Drugs, 2021-2031F |
6.2.3 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Over-the-counter Drugs, 2021-2031F |
6.3 Mongolia Ophthalmic Drugs Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Liquid Ophthalmic Drug Forms, 2021-2031F |
6.3.3 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Solid Ophthalmic Drug Forms, 2021-2031F |
6.3.4 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Semisolid Ophthalmic Drug Forms, 2021-2031F |
6.3.5 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Multicompartment Drug Delivery Systems, 2021-2031F |
6.3.6 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Other Ophthalmic Drug Forms, 2021-2031F |
6.4 Mongolia Ophthalmic Drugs Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.4.3 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Drug Stores, 2021-2031F |
6.4.4 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
6.4.5 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.5 Mongolia Ophthalmic Drugs Market, By Therapeutic Class |
6.5.1 Overview and Analysis |
6.5.2 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Anti-glaucoma, 2021-2031F |
6.5.3 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Anti-infection, 2021-2031F |
6.5.4 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Anti-inflammation, 2021-2031F |
6.5.5 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Anti-allergy, 2021-2031F |
6.5.6 Mongolia Ophthalmic Drugs Market Revenues & Volume, By Others, 2021-2031F |
7 Mongolia Ophthalmic Drugs Market Import-Export Trade Statistics |
7.1 Mongolia Ophthalmic Drugs Market Export to Major Countries |
7.2 Mongolia Ophthalmic Drugs Market Imports from Major Countries |
8 Mongolia Ophthalmic Drugs Market Key Performance Indicators |
8.1 Number of eye health awareness campaigns conducted annually |
8.2 Percentage increase in the use of telemedicine for eye consultations |
8.3 Average wait time for accessing ophthalmic treatment services |
9 Mongolia Ophthalmic Drugs Market - Opportunity Assessment |
9.1 Mongolia Ophthalmic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Mongolia Ophthalmic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Mongolia Ophthalmic Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 Mongolia Ophthalmic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Mongolia Ophthalmic Drugs Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
10 Mongolia Ophthalmic Drugs Market - Competitive Landscape |
10.1 Mongolia Ophthalmic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Mongolia Ophthalmic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here